Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Titan Pharma Investors' Wait Will Be Well Worth It
Seeking Alpha
Wednesday, September 30, 2009 - 11:13am
tags:
Titan, Vanda, Fanapt
Keryx Pharma Could Turn into a Real Winner Down the Road
Seeking Alpha
Wednesday, September 30, 2009 - 11:12am
tags:
Keryx, perifosine, Zerenex
Bayer, Onyx’s Pill Doesn’t Slow Breast Cancer in Second Study
Bloomberg
Wednesday, September 30, 2009 - 11:11am
tags:
Bayer, breast cancer, drug trials, Nexavar, ONYX Pharmaceuticals
Healthcare Takeover Talk Continues
Seeking Alpha
Wednesday, September 30, 2009 - 10:51am
tags:
M&A, Sequenom, Sanofi, Novavas, Ista, Cel-Sci
Orexigen says trial of 2nd obesity drug meets goal
Reuters
Wednesday, September 30, 2009 - 10:50am
tags:
Orexigen, obesity, drug trials, Empatic
Mylan says FDA approved its version of Bristol-Myers drug Sinemet for Parkinson's disease
Yahoo/AP
Wednesday, September 30, 2009 - 10:48am
tags:
Mylan, FDA, Parkinson's Disease, generics, Sinemet, Bristol-Myers Squibb
Are pharma execs in legal jeopardy?
Fierce Pharma
Wednesday, September 30, 2009 - 10:31am
tags:
InterMune
New Deal: Stent Makers Getting Settlement Fever
WSJ Online
Wednesday, September 30, 2009 - 9:53am
tags:
stent, settlements, JNJ, Medtronic, Boston Scientific, Abbott Laboratories
Good News for Novartis
Yahoo/Zacks.com
Wednesday, September 30, 2009 - 9:51am
tags:
Novartis, MS, multiple sclerosis
H1N1 Vaccine Is Top Flu Concern For U.S. Businesses
CNBC
Wednesday, September 30, 2009 - 9:47am
tags:
H1N1, swine flu, vaccines
[video] Top Biotech Stock Picks
TheStreet.com
Wednesday, September 30, 2009 - 7:24am
tags:
biotech, Allos, Gilead Sciences, Vanda, Chelsea Therapeutics, Amgen, Dendreon, Spectrum Pharmaceuticals, Cell Therapeutics
US regulators subpoena documents of brain disease with drugmaker Elan's Tysabri
Yahoo/AP
Wednesday, September 30, 2009 - 6:49am
tags:
Elan, Tysabri, PML, Biogen Idec, MS, multiple sclerosis
Pfizer gets Australia clearance to acquire Wyeth
Marketwatch
Wednesday, September 30, 2009 - 6:10am
tags:
Pfizer, Wyeth, M&A, Australia
Sanofi CEO to Shop for Biotech, Vaccine, Nonprescription Deals
Bloomberg
Wednesday, September 30, 2009 - 6:08am
tags:
Sanofi, Pharma CEOs, Chris Viehbacher, M&A
Cancer Alert Probed as Sanofi, Novo Diabetes Drugs Put to Test
Bloomberg
Tuesday, September 29, 2009 - 9:19pm
tags:
Novo Nordisk, Sanofi, diabetes, cancer, Lantus, liraglutide, insulin
Boston Scientific, J&J Deal is Latest Sign of Stent Suit Detente
WSJ Online
Tuesday, September 29, 2009 - 9:16pm
tags:
JNJ, Boston Scientific, stent, settlements
Pfizer's $68 billion buyout of Wyeth gets clearance in China, still awaiting US clearance
Yahoo/AP
Tuesday, September 29, 2009 - 2:33pm
tags:
Pfizer, Wyeth, M&A, China
FDA delays Glaxo cervical cancer vaccine ruling after death in UK
MSNBC
Tuesday, September 29, 2009 - 1:09pm
tags:
GSK, FDA, Cervarix, HPV, vaccines
The 10Q Detective: Losing Sleep Over Cephalon
Businessweek
Tuesday, September 29, 2009 - 11:10am
tags:
Cephalon, narcolepsy, Provigil
Valeant paying $115 million for drug rights
Yahoo/AP
Tuesday, September 29, 2009 - 11:09am
tags:
Valeant Pharmaceuticals, Dow

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.